ofix-defa14a_20210621.htm

☐		Preliminary Proxy Statement

☐		Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐		Definitive Proxy Statement

☒		Definitive Additional Materials

☐		Soliciting Material Pursuant to §240.14a-12

☒	No fee required.

☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11

	(1)	Title of each class of securities to which transaction applies:

	(2)	Aggregate number of securities to which transaction applies:

	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

	(4)	Proposed maximum aggregate value of transaction:

	(5)	Total fee paid:


☐	Fee paid previously with preliminary materials.

☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.


		(1)		Amount Previously Paid:

		(2)		Form, Schedule or Registration Statement No.:

		(3)		Filing Party:

		(4)		Date Filed:

P.O. BOX 8016, CARY, NC 27512-9903 Orthofix Medical Inc. Important Notice Regarding the Availability of Proxy Materials Shareholders Meeting to be held on June 21, 2021 For Shareholders as of record on April 22, 2021 This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy materials, and to obtain directions to attend meeting, go to: www.proxydocs.com/OFIX To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. For a convenient way to view proxy materials and VOTE go to www.proxydocs.com/OFIX Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions. If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before June 11, 2021. To order paper materials, use one of the following methods. INTERNET www.investorelections.com/OFIX TELEPHONE (866) 648-8133 * E-MAIL paper@investorelections.com When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above. * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Orthofix Medical Inc. Meeting Type: Annual Meeting of Shareholders Date: Monday, June 21, 2021 Time: 09:00 AM, Central Daylight Time Place: Four Seasons Resort and Club Dallas at Las Colinas 4150 North MacArthur Boulevard, Irving, Texas 75038 SEE REVERSE FOR FULL AGENDA

Orthofix Medical Inc. Annual Meeting of Shareholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1, 2, 3, 4 AND 5 PROPOSAL 1. Election of the following director nominees 1.01 Catherine M. Burzik 1.02 Jason M. Hannon 1.03 James F. Hinrichs 1.04 Alexis V. Lukianov 1.05 Lilly Marks 1.06 Michael E. Paolucci 1.07 Jon C. Serbousek 1.08 John E. Sicard 2. Advisory vote on compensation of named executive officers. 3. Approval of Amendment No. 2 to the Amended and Restated 2012 Long-Term Incentive Plan. 4. Approval of Amendment No. 2 to the Second Amended and Restated Stock Purchase Plan. 5. Ratification of the selection of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2021. 6. To consider and act upon any other matters which may properly come before the meeting or any adjournment or postponement thereof.